| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
|---|---|---|---|---|
| Capital Group Central Cash Fund | Short Term | 68,040,746 | $6,804,754,969.00 | 4.88% |
| Philip Morris International, Inc. | Equity | 24,590,854 | $3,944,372,982.00 | 2.83% |
| Broadcom, Inc. | Equity | 8,346,856 | $2,888,846,862.00 | 2.07% |
| Gilead Sciences, Inc. | Equity | 19,619,859 | $2,408,141,494.00 | 1.73% |
| JPMorgan Chase & Co. | Equity | 6,473,197 | $2,085,793,537.00 | 1.5% |
| Taiwan Semiconductor Manufacturing Co., Ltd. | Equity | 42,710,786 | $2,086,566,155.00 | 1.5% |
| CVS Health Corp. | Equity | 23,692,996 | $1,880,276,163.00 | 1.35% |
| Citigroup, Inc. | Equity | 15,366,816 | $1,793,153,759.00 | 1.29% |
| Agnico Eagle Mines, Ltd. | Equity | 9,830,897 | $1,667,144,793.00 | 1.2% |
| EOG Resources, Inc. | Equity | 15,989,113 | $1,679,016,756.00 | 1.2% |
| Nestle SA | Equity | 15,800,358 | $1,570,451,611.00 | 1.13% |
| BAE Systems PLC | Equity | 67,013,192 | $1,540,567,189.00 | 1.11% |
| Industria de Diseno Textil, SA | Equity | 23,389,534 | $1,540,677,461.00 | 1.11% |
| AbbVie, Inc. | Equity | 6,657,611 | $1,521,197,537.00 | 1.09% |
| Amgen, Inc. | Equity | 4,502,034 | $1,473,560,749.00 | 1.06% |